|
English
|
正體中文
|
简体中文
|
2853504
|
|
???header.visitor??? :
45188727
???header.onlineuser??? :
698
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"ferris r l"???jsp.browse.items-by-author.description???
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
|
Kiyota N.;Hasegawa Y.;Takahashi S.;Yokota T.;Yen C.-J.;Iwae S.;Shimizu Y.;Ruey-Long Hong;Goto M.;Kang J.-H.;Sum Kenneth Li W.;Ferris R.L.;Gillison M.;Namba Y.;Monga M.;Lynch M.;Tahara M.; Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
|
Kiyota N.;Hasegawa Y.;Takahashi S.;Yokota T.;Yen C.-J.;Iwae S.;Shimizu Y.;Ruey-Long Hong;Goto M.;Kang J.-H.;Sum Kenneth Li W.;Ferris R.L.;Gillison M.;Namba Y.;Monga M.;Lynch M.;Tahara M.; Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M. |
| 臺大學術典藏 |
2021-03-09T06:45:59Z |
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
|
Yen C.-J.; Kiyota N.; Hanai N.; Takahashi S.; Yokota T.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Li W.S.K.; Ferris R.L.; Gillison M.; Endo T.; Jayaprakash V.; Tahara M. |
| 國立成功大學 |
2020 |
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
|
Yen, C.-J.;Kiyota, N.;Hanai, N.;Takahashi, S.;Yokota, T.;Iwae, S.;Shimizu, Y.;Hong, R.-L.;Goto, M.;Kang, J.-H.;Li, W.S.K.;Ferris, R.L.;Gillison, M.;Endo, T.;Jayaprakash, V.;Tahara, M. |
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
